Asset and development manager Lateral has secured a pre-let to Nuclera at Mortlock House in Cambridge.
The biotech company has taken all 31,248 sq ft of the building on a 10-year lease to establish its new global headquarters and will move from Cambridge Science Park where it has outgrown its current space.
Lateral bought Mortlock House earlier this year in a joint venture with Amazon Capital – the first life science sector purchase for Amazon Property’s new £250 million fund.
Lateral director Rob Beacroft said: “Our unique focus upon delivering service-led lab spaces for a diverse range of occupiers is putting us front of mind for innovative companies like Nuclera. Lateral, like Nuclera, is a dynamic, forward-thinking business, which allowed the bespoke deal to be completed within a matter of weeks.
“We are delighted Nuclera has chosen to move their market-leading technology and research to Mortlock House, and we look forward to announcing further strategic acquisitions over the coming months, as we progressively increase our life sciences portfolio.”
Nuclera co-founder and chief executive Michael Chen said: “Our work and team are expanding at pace. Following our recent series B [capital] raising, we have secured top talent across key positions and are rapidly progressing in our mission to make proteins accessible via game-changing technology.
“We believe Lateral’s unique lab space focus mirrors our own ambition for better service and innovation in this sector.”
JLL and SMB advised Lateral, and Taylor Wessing acted for Nuclera in the deal.
© Eastern Echo (powered by ukpropertyforums.com).
Sign up to receive your free bi-weekly Eastern Echo journal here.
